PharM Assist
0465.030.767 · rovalta.com · 24/09/2026
PharM Assist
Company — Normal situation.
Overview
What does PharM Assist do?
PharM Assist is a company registered in Belgium.
Trend over 19 financial years
| 2024 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||||
| Gross margin | -383 € | -106% | 6 k € | -58.6% | 14,4 k € | +39.2% | 10,4 k € | -2.9% | 10,7 k € | +24.7% | 8,6 k € | -50.2% | 17,2 k € | -1.6% | 17,5 k € | +9.6% | 15,9 k € | -23.3% | 20,8 k € | +895% | -2,6 k € | -188% | -908,7 € | +89.3% | -8,5 k € | -298% | 4,3 k € | +10.5% | 3,9 k € | -74.2% | 15 k € | +263% | -9,2 k € | -130% | 30,4 k € | +75.5% | 17,4 k € |
| EBITDA | -510,6 € | -110% | 4,9 k € | -63.4% | 13,5 k € | +40.1% | 9,6 k € | -2.3% | 9,8 k € | +28.0% | 7,7 k € | -53.0% | 16,4 k € | -1.1% | 16,6 k € | +10.1% | 15 k € | -21.0% | 19 k € | +569% | -4,1 k € | -129% | -1,8 k € | +81.0% | -9,3 k € | -388% | 3,2 k € | +8.2% | 3 k € | -77.7% | 13,4 k € | +228% | -10,5 k € | -136% | 28,8 k € | +89.4% | 15,2 k € |
| Operating result | -510,6 € | -110% | 4,9 k € | -63.4% | 13,5 k € | +40.1% | 9,6 k € | -2.3% | 9,8 k € | +28.0% | 7,7 k € | -44.5% | 13,9 k € | -1.3% | 14 k € | -6.7% | 15 k € | -21.0% | 19 k € | +569% | -4,1 k € | -129% | -1,8 k € | +81.8% | -9,7 k € | -445% | 2,8 k € | +9.5% | 2,6 k € | -71.2% | 8,9 k € | +159% | -15,1 k € | -164% | 23,5 k € | +137% | 9,9 k € |
| Net result | -546,2 € | -117% | 3,1 k € | -63.7% | 8,7 k € | +44.0% | 6 k € | -7.7% | 6,5 k € | +49.4% | 4,4 k € | -47.8% | 8,4 k € | +24.2% | 6,7 k € | -14.5% | 7,9 k € | -51.3% | 16,2 k € | +409% | -5,2 k € | -69.0% | -3,1 k € | +69.5% | -10,1 k € | -664% | 1,8 k € | -14.5% | 2,1 k € | -75.7% | 8,6 k € | +157% | -15 k € | -209% | 13,7 k € | +113% | 6,5 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||||
| Equity | 63,9 k € | -0.8% | 64,4 k € | -5.3% | 68 k € | -0.0% | 68 k € | +8.3% | 62,8 k € | +8.0% | 58,1 k € | +8.1% | 53,8 k € | +18.4% | 45,4 k € | +17.4% | 38,7 k € | +25.5% | 30,8 k € | +110% | 14,7 k € | -26.2% | 19,9 k € | -13.4% | 23 k € | -30.6% | 33,1 k € | -1.2% | 33,5 k € | +6.7% | 31,4 k € | +7.3% | 29,3 k € | -33.9% | 44,3 k € | +4.7% | 42,4 k € |
| Total assets | 63,9 k € | -12.4% | 72,9 k € | +0.9% | 72,2 k € | +0.5% | 71,8 k € | +7.6% | 66,8 k € | +12.0% | 59,6 k € | -1.8% | 60,7 k € | +28.8% | 47,1 k € | -13.3% | 54,4 k € | +31.1% | 41,5 k € | +100% | 20,7 k € | -40.8% | 35 k € | -30.3% | 50,2 k € | -5.4% | 53 k € | -13.0% | 61 k € | +32.2% | 46,1 k € | -6.2% | 49,2 k € | -55.2% | 109,7 k € | +18.6% | 92,5 k € |
| Cash | 57 k € | -16.5% | 68,3 k € | -4.1% | 71,2 k € | +14.5% | 62,2 k € | +5.0% | 59,3 k € | +3.7% | 57,1 k € | +58.4% | 36,1 k € | +29.1% | 28 k € | -34.4% | 42,6 k € | +37.7% | 30,9 k € | +141% | 12,8 k € | +22.1% | 10,5 k € | -4.2% | 11 k € | -49.9% | 21,9 k € | -31.3% | 31,9 k € | +4.7% | 30,4 k € | +6.4% | 28,6 k € | -63.8% | 79,1 k € | +113% | 37,1 k € |
| Debts | – | 8,5 k € | +113% | 4 k € | +10.0% | 3,6 k € | +1.4% | 3,6 k € | +240% | 1 k € | -84.7% | 6,9 k € | +320% | 1,6 k € | -88.5% | 14,2 k € | +34.0% | 10,6 k € | +77.5% | 6 k € | -60.1% | 14,9 k € | -38.2% | 24,1 k € | +21.6% | 19,8 k € | -13.9% | 23,1 k € | +56.7% | 14,7 k € | -21.6% | 18,8 k € | -71.3% | 65,3 k € | +30.4% | 50,1 k € | |
Board of directors
Seen on filing of 26/09/2024 · 1 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2024 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 26/09/2024 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 3 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 18/10/2024 | 25/09/2024 | 21/11/2023 | 16/11/2022 | 18/11/2021 | 16/11/2020 |
| General meeting | 26/09/2024 | 30/08/2024 | 03/11/2023 | 04/11/2022 | 05/11/2021 | 06/11/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
26 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 26/09/2024 | 26/09/2024 | 18/10/2024 | French | |
| Micro model | 30/06/2024 | 30/08/2024 | 25/09/2024 | French | |
| Micro model | 30/06/2023 | 03/11/2023 | 21/11/2023 | French | |
| Micro model | 30/06/2022 | 04/11/2022 | 16/11/2022 | French | |
| Micro model | 30/06/2021 | 05/11/2021 | 18/11/2021 | French | |
| Micro model | 30/06/2020 | 06/11/2020 | 16/11/2020 | French | |
| Micro model | 30/06/2019 | 04/11/2019 | 20/11/2019 | French | |
| Micro model | 30/06/2018 | 02/11/2018 | 26/11/2018 | French | |
| Micro model | 30/06/2017 | 03/11/2017 | 01/12/2017 | French | |
| Abridged model | 30/06/2016 | 04/11/2016 | 02/12/2016 | French | |
| Abridged model | 30/06/2015 | 27/11/2015 | 11/12/2015 | French | |
| Abridged model | 30/06/2014 | 07/11/2014 | 04/12/2014 | French | |
| Abridged model | 30/06/2013 | 22/11/2013 | 17/12/2013 | French | |
| Abridged model | 30/06/2012 | 23/11/2012 | 19/12/2012 | French | |
| Abridged model | 30/06/2011 | 04/11/2011 | 25/11/2011 | French | |
| Abridged model | 30/06/2010 | 05/11/2010 | 15/11/2010 | French | |
| Abridged model | 30/06/2009 | 06/11/2009 | 09/11/2009 | French | |
| Abridged model | 30/06/2008 | 07/11/2008 | 01/12/2008 | French | |
| Abridged model | 30/06/2007 | 02/11/2007 | 29/11/2007 | French | |
| Abridged model | 30/06/2006 | 03/11/2006 | 28/11/2006 | French | |
| Abridged model | 30/06/2005 | 04/11/2005 | 02/12/2005 | French | |
| Abridged model | 30/06/2004 | 05/11/2004 | 24/11/2004 | French | |
| Abridged model | 30/06/2003 | 19/12/2003 | 09/01/2004 | French | |
| Abridged model | 30/06/2002 | 20/12/2002 | 17/01/2003 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 26/09/2024 · 1 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-546,2 €↓
- 2024Annual accounts 20243,1 k €↓
- 2023Annual accounts 20238,7 k €↑
- 2023Name changePharM Assist
- 2022Annual accounts 20226 k €↓
- 2022Name changePHARMASSIST
- 2021Annual accounts 20216,5 k €↑
- 2020Annual accounts 20204,4 k €↓
- 2019Annual accounts 20198,4 k €↑
- 2018Annual accounts 20186,7 k €↓
- 2017Annual accounts 20177,9 k €↓
- 2016Annual accounts 201616,2 k €↑
- 2015Annual accounts 2015-5,2 k €↓
- 2014Annual accounts 2014-3,1 k €↑
- 2013Annual accounts 2013-10,1 k €↓
- 2012Annual accounts 20121,8 k €↓
- 2011Annual accounts 20112,1 k €↓
- 2010Annual accounts 20108,6 k €↑
- 2009Annual accounts 2009-15 k €↓
- 2008Annual accounts 200813,7 k €↑
- 2007Annual accounts 20076,5 k €